PLANAR MYOCARDIAL IMAGING IN THE BABOON MODEL WITH IODINE-123-15-(IODOPHENYL)PENTADECANOIC ACID (IPPA) AND NE-123-15-(P-IODOPHENYL)-3-R,S-METHYLPENTADECANOIC ACID (BMIPP), USING TIME-ACTIVITY CURVES FOR EVALUATION OF METABOLISM
Ic. Dormehl et al., PLANAR MYOCARDIAL IMAGING IN THE BABOON MODEL WITH IODINE-123-15-(IODOPHENYL)PENTADECANOIC ACID (IPPA) AND NE-123-15-(P-IODOPHENYL)-3-R,S-METHYLPENTADECANOIC ACID (BMIPP), USING TIME-ACTIVITY CURVES FOR EVALUATION OF METABOLISM, Nuclear medicine and biology, 22(7), 1995, pp. 837-847
The purpose of this study was to compare by planar myocardial scintigr
aphy the kinetics of iodine-123-15-(iodophenyl)pentadecanoic acid (I-1
23-pPPA and I-123-oPPA), and of odine-123-(p-iodophenyl)-3-R,S-methylp
entadecanoic acid (BMIPP), firstly in normal baboons, and subsequently
after blocking fatty acid oxidation by a carnitine palmitoyl transfer
ase I(CPT1) inhibitor. The induced changes in myocardial metabolism we
re reflected in the dynamic behaviour of the three tracers. pPPA and o
PPA to a large extent, provided information on beta-oxidation changes
in the myocardium: beta-oxidation participation changed from 47% and 5
0%, respectively to 17% and 23% after inhibition. BMIPP provided bette
r images and reflected largely on changed tracer incorporation into th
e neutral lipid pools. The beta-oxidation contributed only about 10% t
owards the metabolic pathway of BMIPP. The information obtained in thi
s study could help determine the tracer of choice for SPECT, whereby m
yocardial viability could optimally be revealed.